Long Ideas - BioLife Solutions, the Bothell, WA based supplier of biopreservation media products and contract manufacturer, has climbed over 100% since our April report on the company. … Continue Reading
Read NowMost Popular - A recently announced collaboration with Array BioPharma (ARRY) on a small molecule HER2 inhibitor may be the best thing to happen to Oncothyreon (ONTY) since … Continue Reading
Read NowLong Ideas - Since we initiated coverage of Cubist Pharmaceuticals (CBST) in mid-May, shares of the antibiotics manufacturer are up over 26%, as the company secured a key … Continue Reading
Read NowLong Ideas - Since making their public debut in February 2012, shares of ChemoCentryx (CCXI) have risen less than 23%, underperforming the NASDAQ Biotechnology Index’s nearly 64% rise … Continue Reading
Read NowMost Popular - As we wrote in a note to PropThink Premium subscribers on Monday July 29 before the market open, an imbalance in the supply of stock … Continue Reading
Read NowLong Ideas - Since making their market debut in March, shares of Enanta Pharmaceuticals (ENTA) have remained virtually flat, excluding a post-IPO pop (shares closed at $17.18 on … Continue Reading
Read NowMost Popular - At the end of June, biotech giant Celgene (CELG) made a $15M investment in a small and obscure biotech for the right-of-first-negotiation to one of its lead … Continue Reading
Read Now